Category: SEC Filings

Item 8.01 Other Events Litigation Relating to the Merger As previously disclosed, on July 7, 2022, Meridian Bioscience, Inc., a corporation organized under the laws of Ohio (“Meridian”), on the one hand, and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea, Columbus Holding Company, a corporation…

Read More “8-K Other Events – MERIDIAN BIOSCIENCE INC (0000794172) September 30” »

Item 1.01 Entry into a Material Definitive Agreement Subscription Agreement On September 29, 2022, Mondee Holdings, Inc. (the “Company”) completed a private placement of the Company’s newly designated Series A Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), and warrants (the “Warrants”) to purchase shares of the Company’s Class A Common Stock, par…

Read More “8-K Material Agrmt Reg FD – Mondee Holdings, Inc. (0001828852) September 29” »

Item 8.01 – Other Events On September 30, 2022, Trinity Capital Inc. issued a press release announcing an adjustment to the conversion rate for its 6.00% Convertible Notes due 2025. This press release is included as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. Item 9.01 – Financial Statements and Exhibits…

Read More “8-K Other Events – Trinity Capital Inc. (0001786108) September 30” »

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On and effective September 30, 2022, Andreas Busch, Ph.D. resigned from his position as Chief Scientific Officer of Cyclerion Therapeutics, Inc. (the “Company”) to pursue another opportunity. Dr. Busch did not advise the Company of…

Read More “8-K Emp Changes – Cyclerion Therapeutics, Inc. (0001755237) September 30” »

Item 1.01 Entry into a Material Definitive Agreement. On September 30, 2022, TriplePoint Venture Growth BDC Corp. (the “Company”) entered into a sales agreement, dated September 30, 2022 (the “Sales Agreement”), with TriplePoint Advisers LLC, TriplePoint Administrator LLC and UBS Securities LLC (the “Sales Agent”), providing for the issuance of up to an aggregate of…

Read More “8-K Material Agrmt – TriplePoint Venture Growth BDC Corp. (0001580345) September 30” »

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Departure of Palvi Mehta On September 30, 2022, the Board of Directors (the “Board”) of 5E Advanced Materials, Inc. (“5E” or the “Company”) accepted the resignation of Palvi Mehta as a member of the Board and all committees thereof, effective…

Read More “8-K Emp Changes – 5E Advanced Materials, Inc. (0001888654) September 30” »

Item 1.01. Entry into a Material Definitive Agreement. On September 30, 2022, Ligand Pharmaceuticals Incorporated (the “Company”) entered into an At-The-Market Equity Offering Sales Agreement (the “Sales Agreement”) with Stifel, Nicolaus & Company, Incorporated (the “Agent”), under which the Company may, from time to time, sell shares of the Company’s common stock having an aggregate…

Read More “8-K Material Agrmt – LIGAND PHARMACEUTICALS INC (0000886163) September 30” »

ITEM 5.03. AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR. Change In Fiscal Year On September 29, 2022, the Board of Directors of Warner Music Group Corp. (the “Company”) approved a change, effective for the 2023 fiscal year, from a modified 52/53-week reporting calendar, in which reporting periods ended on the last…

Read More “8-K – Warner Music Group Corp. (0001319161) September 30” »

Item 8.01 Other Events. On September 30, 2022, CBTX, Inc. (“CBTX”) and Allegiance Bancshares, Inc. (“Allegiance”) issued a joint press release announcing the closing of the merger of equals between Allegiance and CBTX to form Stellar Bancorp, Inc., effective October 1, 2022. ​ Item 9.01 Financial Statements and Exhibits. (d) Exhibits. ​ ​ ​ ​…

Read More “8-K Other Events – CBTX, Inc. (0001473844) September 30” »

Item 8.01 Other Events.On September 30, 2022, Spirit Airlines, Inc. (the “Company” or “Spirit”) was informed that the New York Stock Exchange issued a notice regarding the approval prepayment. As disclosed in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 12, 2022, pursuant to the terms of the…

Read More “8-K Other Events – Spirit Airlines, Inc. (0001498710) September 30” »